High prevalence and correlates of low bone mineral density in young adults with sickle cell disease

American Journal of Hematology

Volumn 81, Issue 4, 2006, Pages 236-241

  Miller, Redonda G ^a,b   Segal, Jodi B ^a   Ashar, Bimal H ^a   Leung, Sophia ^a   Ahmed, Shamim ^a   Siddique, Shabina ^a   Rice, Tasha ^a   Lanzkron, Sophie ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Bone mineral density; DXA; Osteoporosis; Sickle cell disease

Indexed keywords

HEMOGLOBIN S; ZINC;

ADULT; ARTICLE; BONE DENSITY; BONE TURNOVER; CLINICAL ARTICLE; DISEASE COURSE; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOREARM; FRACTURE; HIP; HUMAN; HYPOXEMIA; LUMBAR SPINE; MALE; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SICKLE CELL ANEMIA; SPINE; ZINC BLOOD LEVEL;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ANOXIA; BONE DENSITY; BONE REMODELING; DENSITOMETRY, X-RAY; FEMALE; FRACTURES, BONE; HEMOGLOBIN, SICKLE; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE; RISK; SEX FACTORS;

EID: 33645727027     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20541     Document Type: Article

References (31)

1. nd edition. Baltimore, MD: Williams and Wilkins; 1996.
2. Almeida A, Roberts I. Bone involvement in sickle cell disease. Br J Haematol 2005;129:482-490.
3. Omojola MF, Annobil S, Adzaku F, Addae SK, Mohammed S. Bone changes in sickle cell anaemia. East Afr Med J 1993;70:154-158.
4. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. N Engl J Med 1995;332:767-773.
5. Kelepouris N, Harper KD, Gannon FG, et al. Severe osteoporosis in men. Ann Intern Med 1995;123:452-460.
6. Soliman AT, Bererhi H, Darwish A, Alzalabani MM, Wali Y, Ansari B. Decreased bone mineral density in prepubertal children with SCD: correlation with growth parameters, degree of siderosis and secretion of growth factors. J Trop Pediatr 1998;44:194-198.
7. VanderJagt DJ, Bonnett C, Okolo SN, Glew RH. Assessment of the bone status of Nigerian children and adolescents with sickle cell disease using calcaneal ultrasound and serum markers of bone metabolism. Calcif Tissue Int 2002;71:133-140.
8. Barden EM, Kawachak DA, Ohene-Frempong K, Stallings VA, Zemel BS. Body composition in children with sickle cell disease. Am J Clin Nutr 2002;76:218-225.
9. Leonard MB, Zemel BS, Kawchak DA, Ohene-Frempong K, Stallings V. Plasma zinc status, growth, and maturation in children with sickle cell disease. J Pediatr 1998;132:467-471.
10. Brinker MR, Thomas KA, Meyers SJ, et al. Bone mineral density of the lumbar spine and proximal femur is decreased in children with sickle cell anemia. Am J Orthop 1998;27:43-49.
11. Woods KF, Ramsey LT, Callahan LA, et al. Body composition in women with sickle cell disease. Ethn Dis 2001;11:30-35.
12. Nelson DA, Rizvi S, Bhattacharyya T, Ortega J, Lachant N, Swerdlow P. Trabecular and integral bone density in adults with sickle cell disease. J Clin Densitom 2003;6:125-129.
13. Westerman MP, Bailey K, Freels S, Schlegel R, Williamson P. Assessment of painful episode frequency in sickle cell disease. Am J Hematol 1997;54:183-188.
14. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease: rates and risk factors. N Engl J Med 1991;325;11-16.
15. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crisis in sickle cell anemia. N Engl J Med 1995;332:l317-1322.
16. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO study group. World Health Org Tech Rep Ser 1994;843:1-129.
17. Statistical applet resource: http://www-stat-class.stanford.edu/ pediatric-bones. Accessed May 2005.
18. National Osteoporosis Foundation. Osteoporosis: review of the evidence for prevention, diagnosis and cost-effectiveness analysis. Osteoporos Int 1998;8:S1-S88.
19. Puffer S, Torgerson DJ, Sykes D, Brown P, Cooper C. Health care costs of women with symptomatic vertebral fractures. Bone 2004;35:383-386.
20. Braithwaite RS, Col NF, Wong JB. Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc 2003;51:364-370.
21. Furstenberg AL, Mezey MD. Differences in outcome between black and white elderly hip fracture patients. J Chronic Dis 1987;40:931.
22. Jacobsen SJ, Goldberg J, Miles TP, Brody JA, Stiers W, Rimm AA. Race and sex differences in mortality following fracture of the hip. Am J Public Health 1992;82:1147-1150.
23. Lowe NM, Lowe NM, Fraser WD, Jackson MJ. Is there a potential therapeutic value of copper and zinc for osteoporosis? Proc Nutr Soc 2002;61:181-185.
24. Gur A, Coplan L, Nas K, et al. The role of trace minerals in the pathogenesis of postmenopausal osteoporosis and a new effect of calcitonin. J Bone Miner Metab 2002;20:39-43.
25. Prasad AS, Cossack ZT. Zinc supplementation and growth in sickle cell disease. Ann Intern Med 1984;100:367-371.
26. Prasad AS. Zinc deficiency in sickle cell disease. Prog Clin Biol Res 1984;165:49-58.
27. Zemel BS, Kawachak DA, Fung EB, Ohene-Frempong K, Stallings VA. Effect of zinc supplementation on growth and body composition in children with sickle cell disease. Am J Clin Nutr 2002;75:300-307.
28. Nesby-O'Dell S, Scanlon KS, Cogswell ME, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 2002;76:187-192.
29. Osegbe DN, Akinyanju OO. Testicular dysfunction in men with sickle cell disease. Postgrad Med J 1987;63:95-98.
30. Singhal A, Gabay L, Serjeant GR. Testosterone deficiency and extreme retardation of puberty in homozygous sickle-cell disease. West Indian Med J 1995;44:20-23.
31. Daniell HW. Hypogonadism in men consuming sustained-action oral opioids. J Pain 2002;3:377-384.